Sinclair Pharma
Alan Olby is the current Chief Financial Officer at Sinclair Pharma. Alan has over 15 years of experience in finance and accounting. Prior to joining Sinclair Pharma, they were the Financial Controller at Xenova Group PLC from September 2003 to August 2005. Before that, they were the Financial Controller at KS Biomedix Ltd from April 2002 to September 2003. Alan is a certified public accountant and has a bachelor's degree in accounting from the University of Leeds.
Alan Olby's educational career began at the University of Exeter, where they earned a BA Hons in Economics. Alan then went on to study at King's School Canterbury.
They work with Jayne Burrell - Group General Counsel and Company Secretary, Kamal Abbasi - Head of China & Asia, and Nairn Mcmaster - Chief Commercial Officer. Alan Olby reports to Chris Spooner, Chief Executive Officer.
This person is not in any offices
Sinclair Pharma
Headquartered in London and a subsidiary of Huadong Medicine Ltd. Sinclair employs over 200 people, directly operating in Western Europe, US, South Korea, Mexico and Brazil, and via distributors around the world.